Latest News
Conference Coverage
PPI-fracture link can’t be ruled out
PHILADELPHIA – While observational studies provide some evidence of a modest...
From the Journals
Premature death from heart disease hits Asian subgroups hard
Asian Indian, Filipino, and Vietnamese populations showed the highest mortality from heart disease among Asian subgroups.
From the Journals
Long-term metformin offsets diabetes in patients with higher glucose/HbA1c, history of gestational diabetes
Long-term metformin was tied to a 41% reduction in diabetes development in women with a history of gestational diabetes.
Feature
Death by a thousand clicks
The U.S. government claimed that turning American medical charts into electronic records would make health care better, safer, and cheaper. Ten...
News
ACC, AHA release first cardiovascular disease primary prevention guideline
“We made the social determinants of health front and center. With many people, clinicians don’t ask whether they have access to healthy foods or a...
Feature
Match Day 2019: Residency spots increase, but improvements needed
For the seventh straight year, the Main Residency Match experienced record growth, with more spots for residency programs and a higher number of...
From the Journals
Bempedoic acid safely dropped LDL, now seeks FDA approval
From the Journals
Consider individualized testosterone protocol for transgender acne
Increased BMI and smoking raise risk of acne in transgender men treated with masculinizing doses of testosterone.
Feature
Prior authorization an increasing burden
Insurers are not following the 2018 consensus statement on improving the prior authorization process, the AMA says.
From the Journals
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
From the Journals
Semaglutide plus SGLT2 inhibitors improves glycemic control in type 2 diabetes
Once-weekly treatment with the GLP-1 RA semaglutide helped most patients with type 2 diabetes on SGLT2 inhibitors meet their glycemic targets and...